Dear VisitorBanyan Biomarkers has been acquired by bioMérieux, a global company specializing in in vitro diagnostics and infectious diseases.
For more information about Banyan Biomarkers please refer to the contact page or contact bioMérieux directly.
Our Mission
"Pioneer the innovation, development, and commercialization of biomarkers to accurately
and quickly diagnose traumatic brain injuries."
Evidence Based
Manage patients with a test based on data and not subjective interpretation
Improve Patient Outcomes
Identify and triage patients that need additional medical assistance
Safety
Reduce radiation exposure from unnecessary CT scans